69 Best Cell Therapy Startups to Watch in 2025

The Definitive Seedtable Ranking of Cell Therapy Startups

We track 71,000+ companies and rank them dynamically using our Seedtable Score – a score that uses quantitative and qualitative data points to signal the momentum behind a company. We then monitor the list manually leveraging our expertise as founders and investors.

There are 171 start-ups with an aggregate funding of $5.8b. The average funding per company in this subset is $84.6m.

Last update to the database: Feb 18, 2025. See changelog.

Track over 71,000 companies

Discover
Fast-growing Global startups

Seedtable uses technology and people to track over 71,000 companies to help you find the right ones to partner with.

Pricing + Sign up
OncoImmune logo

OncoImmune

A clinical-stage biopharmaceutical company engaging in drug discovery and drug development for treating autoimmune disease and cancer.

5

Funding Rounds

$76.5m

Money raised

Senti Biosciences logo

Senti Biosciences

Senti Biosciences is a synthetic biology company.

2

Funding Rounds

$158.0m

Money raised

BlueRock Therapeutics logo

BlueRock Therapeutics

A biotechnology company developing engineered cell therapies for treating diseases in neurology, cardiology and autoimmunity.

1

Funding Rounds

$225.0m

Money raised

Orig3n logo

Orig3n

Orig3n is a biotechnology company developing personalized regenerative medicine treatments based on patient genetic profiles.

5

Funding Rounds

$111.8m

Money raised

Kuur Therapeutics logo

Kuur Therapeutics

Kuur Therapeutics focuses on the development of CAR-NKT cell therapies platform for applications in cancer treatment.

6

Funding Rounds

$190.5m

Money raised

Locus Biosciences logo

Locus Biosciences

Locus Biosciences is a biotechnology company developing CRISPR-Cas3-engineered precision antibacterial products.

8

Funding Rounds

$117.5m

Money raised

Promethera Biosciences logo

Promethera Biosciences

Promethera Biosciences is a biotechnology company developing regenerative medicine treatments for liver diseases.

5

Funding Rounds

$103.1m

Money raised

ViaCyte logo

ViaCyte

ViaCyte is a biotechnology company using stem cells to create pancreatic beta cell precursors for treating diabetes.

16

Funding Rounds

$328.8m

Money raised

Cell Design Labs logo

Cell Design Labs

A biotechnology company founded in 2015 which operates as a subsidiary of Gilead Sciences and Kite Pharma. The company developed a platform for custom cell engineering called synNotch to be used for anticancer therapies. Their system can also be used to develop cell-based therapies for autoimmune and degenerative disorders.

1

Funding Rounds

$34.4m

Money raised

Stemline Therapeutics logo

Stemline Therapeutics

A biopharmaceutical company developing therapeutics to attack cancer stem cells.

2

Funding Rounds

$13.8m

Money raised

EpiBone logo

EpiBone

EpiBone is a biotechnology startup company developing bone reconstruction solutions using stem cells. Nina Tandon, Sarindr Bhumiratana, Gordana Vunjak-Novakovic, and Sidney Eisig founded EpiBone in 2013 and the company is headquartered in New York City, New York.

1

Funding Rounds

EdiGene logo

EdiGene

A biotechnology company using genetic editing technologies to develop therapies for the treatment of cancer and genetic diseases.

9

Funding Rounds

$262.0m

Money raised

Obsidian Therapeutics logo

Obsidian Therapeutics

Develops novel cell and gene therapies with pharmacologic operating systems.

2

Funding Rounds

$164.5m

Money raised

3T Biosciences logo

3T Biosciences

3T Biosciences is a biotechnology company developing immunotherapies.

3

Funding Rounds

$52.0m

Money raised

Betalin Therapeutics logo

Betalin Therapeutics

Biological micro-pancreas for insulin-dependent diabetics company

4

Funding Rounds

$5.1m

Money raised

Bit.bio logo

Bit.bio

Bit.bio is a biotechnology company that aims to operate within human cells through means of coding and biology.

3

Funding Rounds

$183.9m

Money raised

Tmunity Therapeutics logo

Tmunity Therapeutics

Tmunity Therapeutics is a biotechnology company developing t-cell immunotherapies for the treatment of human diseases.

5

Funding Rounds

$425.0m

Money raised

Encellin logo

Encellin

Encellin is a biotechnology company developing diabetes therapeutics using insulin responsive cells.

1

Funding Rounds

$5.9m

Money raised

Celdara Medical logo

Celdara Medical

Celdara Medical is a biotechnology company helping turn academic innovations into medical products.

1

Funding Rounds

$1.7m

Money raised

Eureka Therapeutics, Inc logo

Eureka Therapeutics, Inc

Eureka Therapeutics is a biotechnology company developing immunotherapies for the treatment of cancer.

2

Funding Rounds

$105.0m

Money raised

Kiadis Pharma logo

Kiadis Pharma

Kiadis Pharma is a biotechnology company developing stem cell regenerative medicine treatments for blood cancers and blood disorders.

1

Funding Rounds

$12.8m

Money raised

Novadip Biosciences logo

Novadip Biosciences

Novadip Biosciences is a biotechnology company developing regenerative medicines using stem cells.

2

Funding Rounds

$82.0m

Money raised

GentiBio logo

GentiBio

GentiBio, Inc. is a biotherapeutics company developing engineered regulatory T cells (Tregs) therapies for immunology.

2

Funding Rounds

$177.0m

Money raised

Gadeta logo

Gadeta

Gadeta is a biotechnology company developing immunotherapies for treating cancer.

1

Funding Rounds

$7.0m

Money raised

Kyverna Therapeutics logo

Kyverna Therapeutics

Kyverna is a cell therapy company engineering a new class of curative living medicines for inflammatory and autoimmune diseases.

2

Funding Rounds

$110.0m

Money raised

Ossium Health logo

Ossium Health

Ossium is building the world's first bone marrow bank to treat blood cancers, improve organ transplantation, and repair damage

3

Funding Rounds

$73.4m

Money raised

Immusoft logo

Immusoft

Immusoft is a biotechnology company developing a platform for the insertion of therapeutic genes into immune cells for the treatment of a variety of genetic diseases.

11

Funding Rounds

$37.9m

Money raised

Locate Bio logo

Locate Bio

Locate Bio is a biotechnology developing cell and gene therapies for treating damaged tissues and organs.

9

Funding Rounds

$59.1m

Money raised

Trailhead Biosystems logo

Trailhead Biosystems

Trailhead Biosystems is a biotechnology company developing cell therapy products.

3

Funding Rounds

$17.2m

Money raised

STEMCELL Technologies logo

STEMCELL Technologies

A Canadian biotechnology company that develops specialty cell culture media, cell isolation systems and accessory products for life science research.

1

Funding Rounds

$15.0m

Money raised

Abcuro, Inc. logo

Abcuro, Inc.

Abcuro develops immunotherapies to treat autoimmunity and cancer.

4

Funding Rounds

$72.3m

Money raised

Carisma Therapeutics logo

Carisma Therapeutics

Carisma Therapeutics is a biotechnology company founded in 2016 to bring the potheyr of adoptive cellular immunotherapy to solid tumor patients through a novel platform using chimeric antigen receptor macrophages (CARMA).

2

Funding Rounds

$112.0m

Money raised

Refuge Biotechnologies logo

Refuge Biotechnologies

Refuge Biotechnologies is a biotechnology company that uses CRISPR and cell therapy technologies for treating cancer.

2

Funding Rounds

$33.9m

Money raised

American Gene Technologies logo

American Gene Technologies

AGT is developing and commercializing gene and cell therapy and targeting major diseases, including HIV/AIDS, Phenylketonuria (PKU) and Hepatocellular carcinoma.

4

Funding Rounds

$6.0m

Money raised

A2 Biotherapeutics, Inc logo

A2 Biotherapeutics, Inc

A2 Biotherapeutics, Inc. is a biotechnology research company developing T-cell therapies designed to attack solid tumors while sparing normal cells

1

Funding Rounds

$71.5m

Money raised

TeVideo Biodevices logo

TeVideo Biodevices

TeVido Biodevices is a biotechnology company developing cell therapy products for restoring lost skin pigment.

4

Funding Rounds

$1.4m

Money raised

PACT Pharma logo

PACT Pharma

PACT Pharma is synthesizing neo-epitope targeted T cells and producing a personalized adoptive cell therapy designed to benefit each cancer patient.

3

Funding Rounds

$200.0m

Money raised

StemBioSys logo

StemBioSys

StemBioSys is a biotechnology company developing regenerative medicines using stem cells.

1

Funding Rounds

$1.5m

Money raised

Mogrify logo

Mogrify

Mogrify is developing tailored cellular conversions that power future cell therapies.

8

Funding Rounds

$84.5m

Money raised

Biosceptre logo

Biosceptre

Biosceptre is a Cambridge, Cambridgeshire-based company developing diagnostic tools and biomarkers.

3

Funding Rounds

$13.2m

Money raised

Tactiva Therapeutics logo

Tactiva Therapeutics

Tactiva Therapeutics is a biotechnology company developing cancer immunotherapies.

1

Funding Rounds

$35.0m

Money raised

Stemedica Cell Technologies logo

Stemedica Cell Technologies

Stemedica Cell Technologies is a biopharmaceutical company developing and manufacturing adult stem cells and stem cell factors for research institutions and hospitals for pre-clinical and clinical studies

1

Funding Rounds

$22.0m

Money raised

Encoded Therapeutics, Inc. logo

Encoded Therapeutics, Inc.

Encoded Therapeutics is a developer of genomics-driven precision medicine targeting and treating genetic diseases and disorders.

4

Funding Rounds

$343.1m

Money raised

Cytonus Therapeutics logo

Cytonus Therapeutics

Cytonus Therapeutics is a biotechnology company developing adaptive cellular therapies for treating immune-oncology and inflammatory diseases.

4

Funding Rounds

$2.6m

Money raised

Universal Cells logo

Universal Cells

Universal Cells is a biotechnology company developing regenerative medicine using stem cells.

1

Funding Rounds

$60.0k

Money raised

Qihan Biotech logo

Qihan Biotech

Qihan Biotech is a hangzhou-based biotech company focused on organ transplantation founded in 2017 by Luhan Yang.

1

Funding Rounds

$67.0m

Money raised

Anagenesis Biotechnologies logo

Anagenesis Biotechnologies

Anagenesis Biotechnologies is a biotechnology company developing pre-clinical stem cell therapies for treating genetic and age-related muscle degenerative diseases.

1

Funding Rounds

$3.4m

Money raised

Targazyme logo

Targazyme

Targazyme is a biotechnology company focused on improving survival and quality of life for cancer patients using stem cell transplantation, immunotherapy, regenerative medicine, and gene therapy.

1

Funding Rounds

$2.5m

Money raised

Asklepios Biopharmaceutical logo

Asklepios Biopharmaceutical

Asklepios Biopharmaceutical is a company in North Carolina.

4

Funding Rounds

$241.9m

Money raised

TILT Biotherapeutics logo

TILT Biotherapeutics

TILT Biotherapeutics is a biotechnology company developing t-cell therapies using onolytic viruses for treating cancer.

2

Funding Rounds

$22.0m

Money raised

Taiga Biotechnologies logo

Taiga Biotechnologies

Taiga Biotechnologies is a biotechnology company developing blood stem cell therapies for treating infectious diseases and cancer.

1

Funding Rounds

$40.0m

Money raised

Cellares logo

Cellares

Cellares is a biotechnology and cell therapy company founded in 2019 by Fabian Gerlinghaus, Alex Pesch, and Omar Kurdi.

1

Funding Rounds

$82.0m

Money raised

NewLink Genetics logo

NewLink Genetics

NewLink Genetics is a biopharmaceutical company focused on the discovery and development of immuno-oncology products.

4

Funding Rounds

$37.4m

Money raised

Cytomos logo

Cytomos

Cell analysis technology provider.

4

Funding Rounds

$18.4m

Money raised

Elixirgen Therapeutics logo

Elixirgen Therapeutics

Elixirgen Therapeutics is a Baltimore-based biotechnology company.

3

Funding Rounds

$13.9m

Money raised

Vineti logo

Vineti

Vineti is a cloud-based cell-therapy management system founded in 2016 by Razmik Abnous.

6

Funding Rounds

$152.3m

Money raised

Unum Therapeutics logo

Unum Therapeutics

Unum Therapeutics is a biotechnology company developing cell therapy products for cancer immunotherapy applications.

1

Funding Rounds

$104.4m

Money raised

Convalesce logo

Convalesce

Convalesce is a company developing a stem cell based therapy for neurological conditions that leads to degeneration of neurons, like Parkinson's.

1

Funding Rounds

$250.0k

Money raised

Semma Therapeutics logo

Semma Therapeutics

Semma Therapeutics is a biotechnology company making regenerative medicine therapies using stem cells.

2

Funding Rounds

$114.0m

Money raised

Kytopen logo

Kytopen

Kytopen is a mircrofluidics company founded in 2017 by Paulo Garcia.

9

Funding Rounds

$42.4m

Money raised

Triumvira Immunologics logo

Triumvira Immunologics

Triumvira Immunologics is an adoptive Immunotherapy founded by Jonathan Bramson.

3

Funding Rounds

$171.2m

Money raised

Medeor Therapeutics logo

Medeor Therapeutics

Medeor Therapeutics is a biotechnology company developing personalized cellular immunotherapies to improve health outcomes of patients receiving organ transplants.

1

Funding Rounds

$57.0m

Money raised

WindMIL Therapeutics logo

WindMIL Therapeutics

WindMIL Therapeutics is a biotechnology company developing cell therapy products for treating cancer.

1

Funding Rounds

$5.0m

Money raised

Aruna Biomedical, Inc. logo

Aruna Biomedical, Inc.

Aruna Biomedical, Inc. is a stem Cell Research Products founded in 2003 by Tracey Worthington-Stice.

14

Funding Rounds

$73.9m

Money raised

Cellino logo

Cellino

Cellino (also known as Cellino Biotech) is a Cambridge, MA-based biotechnology company.

6

Funding Rounds

$93.1m

Money raised

Aspen Neuroscience logo

Aspen Neuroscience

Aspen Neuroscience develops autologous iPSC-derived cell replacement therapies for Parkinson’s disease and other CNS disorders.

3

Funding Rounds

$224.0m

Money raised

Personalized Stem Cells logo

Personalized Stem Cells

Personalized Stem Cells is a biotechnology company developing stem cell therapies for treating osteoarthritis, tendon/ligament injuries, and back pain.

2

Funding Rounds

$5.5m

Money raised

RepliCel Life Sciences logo

RepliCel Life Sciences

RepliCel Life Sciences is a biotechnology company developing regenerative medicines primarily using autologous cell therapy.

1

Funding Rounds

$594.1k

Money raised

Minerva Biotechnologies logo

Minerva Biotechnologies

Minerva Biotechnologies is a clinical-stage biopharmaceutical company focused on developing immunotherapies for solid tumor cancers and cellular therapies for regenerative medicine.

8

Funding Rounds

$113.7m

Money raised